159 related articles for article (PubMed ID: 25868275)
41. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice].
Wan SJ; Yang F; Huang XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932
[TBL] [Abstract][Full Text] [Related]
42. A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence.
Voss M; Pinkert S; Kespohl M; Gimber N; Klingel K; Schmoranzer J; Laue M; Gaida M; Kloetzel PM; Beling A
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458499
[TBL] [Abstract][Full Text] [Related]
43. Poly(rC) binding protein 1 benefits coxsackievirus B3 infection via suppressing the translation of p62/SQSTM1.
He HY; You Z; Ouyang T; Zhao G; Chen LJ; Wang Q; Li JY; Ye X; Zhang MH; Yang D; Ge XY; Qiu Y
Virus Res; 2022 Sep; 318():198851. PubMed ID: 35764193
[TBL] [Abstract][Full Text] [Related]
44. Coxsackievirus B3 induces crosstalk between autophagy and apoptosis to benefit its release after replicating in autophagosomes through a mechanism involving caspase cleavage of autophagy-related proteins.
Xin L; Xiao Z; Ma X; He F; Yao H; Liu Z
Infect Genet Evol; 2014 Aug; 26():95-102. PubMed ID: 24836289
[TBL] [Abstract][Full Text] [Related]
45. MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells.
Pryshliak M; Hazini A; Knoch K; Dieringer B; Tolksdorf B; Solimena M; Kurreck J; Pinkert S; Fechner H
FEBS Lett; 2020 Feb; 594(4):763-775. PubMed ID: 31643074
[TBL] [Abstract][Full Text] [Related]
46. Identification of gene expression profiles in HeLa cells and HepG2 cells infected with Coxsackievirus B3.
Rassmann A; Martin U; Saluz HP; Peter S; Munder T; Henke A
J Virol Methods; 2013 Jan; 187(1):190-4. PubMed ID: 23000448
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Wilsky S; Sobotta K; Wiesener N; Pilas J; Althof N; Munder T; Wutzler P; Henke A
Arch Virol; 2012 Feb; 157(2):259-69. PubMed ID: 22075919
[TBL] [Abstract][Full Text] [Related]
48. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
Martin U; Jarasch N; Nestler M; Rassmann A; Munder T; Seitz S; Zell R; Wutzler P; Henke A
Apoptosis; 2007 Mar; 12(3):525-33. PubMed ID: 17211569
[TBL] [Abstract][Full Text] [Related]
49. Replication and persistence of coxsackieviruses B3 in human fibroblasts.
Tonew M; Hartmann M; Schmidtke M; Stelzner A
Zentralbl Bakteriol; 1995 Jan; 282(1):92-101. PubMed ID: 7734835
[TBL] [Abstract][Full Text] [Related]
50. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
51. Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides.
Wang A; Cheung PK; Zhang H; Carthy CM; Bohunek L; Wilson JE; McManus BM; Yang D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1043-52. PubMed ID: 11257014
[TBL] [Abstract][Full Text] [Related]
52. Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I.
Cornell CT; Kiosses WB; Harkins S; Whitton JL
J Virol; 2007 Jul; 81(13):6785-97. PubMed ID: 17442717
[TBL] [Abstract][Full Text] [Related]
53. Rapid Dissemination and Monopolization of Viral Populations in Mice Revealed Using a Panel of Barcoded Viruses.
McCune BT; Lanahan MR; tenOever BR; Pfeiffer JK
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666382
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.
Yuan J; Stein DA; Lim T; Qiu D; Coughlin S; Liu Z; Wang Y; Blouch R; Moulton HM; Iversen PL; Yang D
J Virol; 2006 Dec; 80(23):11510-9. PubMed ID: 16987987
[TBL] [Abstract][Full Text] [Related]
55. Coxsackievirus B3 infection induces autophagic flux, and autophagosomes are critical for efficient viral replication.
Shi X; Chen Z; Tang S; Wu F; Xiong S; Dong C
Arch Virol; 2016 Aug; 161(8):2197-205. PubMed ID: 27224983
[TBL] [Abstract][Full Text] [Related]
56. Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal.
Lim BK; Nam JH; Gil CO; Yun SH; Choi JH; Kim DK; Jeon ES
Virus Res; 2005 Nov; 113(2):153-7. PubMed ID: 15993506
[TBL] [Abstract][Full Text] [Related]
57. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components.
Ye X; Zhang HM; Qiu Y; Hanson PJ; Hemida MG; Wei W; Hoodless PA; Chu F; Yang D
PLoS Pathog; 2014 Apr; 10(4):e1004070. PubMed ID: 24722419
[TBL] [Abstract][Full Text] [Related]
58. [Rapamycin affects eIF- 4E expression in rat myocardial fibroblasts infected by Coxsackievirus B3].
Chen CY; Sun YN; Yang ZC; Long YQ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):587-90. PubMed ID: 18082048
[TBL] [Abstract][Full Text] [Related]
59. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
[TBL] [Abstract][Full Text] [Related]
60. Tyrosine phosphorylation events during coxsackievirus B3 replication.
Huber M; Selinka HC; Kandolf R
J Virol; 1997 Jan; 71(1):595-600. PubMed ID: 8985388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
